Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection
- 22 August 2006
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (9) , 1633-1636
Abstract
The progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with environmental factors. A “clotting process” is involved in fibrogenesis. ABO blood group distribution is associated with thrombotic disease, non-O blood group increasing the risk of venous thrombosis. The aim of the study was to investigate whether ABO blood type contributes to the severity of fibrosis. We studied blood group distribution in 346 French patients with HCV infection who underwent biopsies. The distribution of non-O blood group was 40%, 55%, 62%, 71%, and 73% for the F0, F1, F2, F3 and F4 fibrosis scores, respectively. Non-O blood group was associated with increased severity of fibrosis, even after adjustment on gender, age, duration of infection, and alcohol consumption (odds ratio 1.8, 95% confidence interval 1.0–2.9; P=.04). Non-O blood group is an independent risk factor for the progression of liver fibrosis in HCV infection.Keywords
This publication has 22 references indexed in Scilit:
- Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis CHepatology, 2004
- Genetic and Acquired Thrombotic Factors in Chronic Hepatitis CAmerican Journal of Gastroenterology, 2004
- Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infectionGut, 2003
- Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitisGut, 2003
- Natural history of chronic hepatitis CHepatology, 2002
- Elevated Factor VIII Levels and the Risk of ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertensionHepatology, 1995
- Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosisThe Lancet, 1995
- Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis CHepatology, 1994
- VENOUS THROMBOEMBOLIC DISEASE AND ABO BLOOD TYPEThe Lancet, 1969